A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide.
Clin Case Rep
; 9(5): e04118, 2021 May.
Article
en En
| MEDLINE
| ID: mdl-34026158
ABSTRACT
Long-acting somatostatin analogs, including lanreotide slow release (LAN-SR) and octreotide long-acting release (OCT-LAR), can improve hypoglycemia in insulinoma. LAN-SR may be more beneficial in some patients with insulinoma than OCT-LAR.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Clin Case Rep
Año:
2021
Tipo del documento:
Article